Thursday, July 24, 2025
LBNN
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • Documentaries
No Result
View All Result
LBNN

Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network

Simon Osuji by Simon Osuji
September 29, 2024
in Technology
0
Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

BayerBayer announced today the inauguration of its new life science incubator, Bayer Co.Lab Shanghai, in the Shanghai Innovation (SH-INNO) Park at the heart of China’s largest biopharma cluster, Zhangjiang, Shanghai. Bayer Co.Lab is part of the global network of life science incubators situated in key innovation hubs, including Cambridge (USA), Kobe (Japan), and Berlin (Germany). The establishment of Bayer Co.Lab Shanghai represents a major milestone in Bayer’s external innovation strategy, aimed at fostering open collaboration within the biotechnology ecosystem. The incubator will provide state-of-the art laboratories, collaborative working space and tailored support for start-ups, serving as a crucial pillar in advancing local innovation across the entire biopharmaceutical value chain.


“Shanghai is a nexus of universities, start-ups, incubators, and investors, supported by a booming innovation ecosystem,” said Juergen Eckhardt, MD, Head of Business Development & Licensing at Bayer Pharmaceuticals. “The city draws strength from a deep talent pool and a strong entrepreneurial culture, enhancing its capacity for innovation. With Bayer Co.Lab Shanghai, we provide access to Bayer’s expertise in cell and gene therapy and oncology, and connect start-ups to our international innovation and partner networks in a nurturing ecosystem to grow and thrive.”

Related posts

A TCG offshoot pulls in $400M for biotech startup creation

A TCG offshoot pulls in $400M for biotech startup creation

July 24, 2025
Nigeria inaugurates working group on national carbon budget – EnviroNews

Nigeria inaugurates working group on national carbon budget – EnviroNews

July 24, 2025


China is home to the world’s second largest pharmaceutical market, and its innovation capabilities are among the world’s top two. The country’s pharmaceutical research and industrial development has entered a new phase of innovation and is playing an increasingly important role in the global pharmaceutical value chain.


With more than 140 years of presence in China, Bayer continues to expand its innovation footprint. To date, Bayer has established two global research & development (R&D) centers and four world-class production facilities in China. Furthermore, China is included in more than 80% of Bayer’s major multi-center clinical trials, covering both early and late-stage clinical development. Bayer is also collaborating with leading academic institutions, such as Tsinghua University and Peking University, to accelerate the translation of early research into new drug development, further enhancing China’s pharmaceutical R&D capabilities. These collaborations have resulted in more than 100 joint research projects, making Bayer a model for collaborative innovation in China’s pharmaceutical sector.


The launch of Bayer Co.Lab Shanghai underscores Bayer’s continued commitment to investing in innovation in China and reinforces its determination to grow in this key market. Through Bayer Co.Lab, Bayer will deepen local partnerships and accelerate co-creation in China to drive healthcare innovation in China and globally.


In November 2024, Bayer Co.Lab Berlin will open on the company’s global Pharmaceuticals divisional headquarters, which will serve as a hub for breakthrough discoveries, with a particular focus on cell and gene therapies and modality platforms.

About Bayer Co.Lab

Bayer Co.Lab is a pioneering global network of life science incubators focused on disruptive innovation and scientific breakthroughs. With strategic locations around the world, in Berlin, Germany; Cambridge, USA; Kobe, Japan; and Shanghai, China, Bayer Co.Lab connects early-stage entrepreneurs with world-class expertise, resources, and global networks – with no strings attached. We empower visionary startups by providing state-of-the-art facilities, expert mentorships, and a vibrant community where they can transform groundbreaking ideas into impactful healthcare solutions. Join us in shaping the future of healthcare and Bringing Your Brilliant Ideas to Life.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros.

Source link

Previous Post

How Could the SEC Appealing The Ripple Case Impact XRP

Next Post

Nasdaq Warns Alliance Could De-Stabilize US Dollar into Crisis

Next Post
Nasdaq Warns Alliance Could De-Stabilize US Dollar into Crisis

Nasdaq Warns Alliance Could De-Stabilize US Dollar into Crisis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

10 lessons from African billionaires on achieving business growth

10 lessons from African billionaires on achieving business growth

4 months ago
Top 10 best African countries for women in 2024

Top 10 best African countries for women in 2024

1 year ago
Boeing welcomes USAF interest in light-attack version of T-7 trainer

Boeing welcomes USAF interest in light-attack version of T-7 trainer

2 years ago
Ride sharing and ride hailing startups in Africa

Ride sharing and ride hailing startups in Africa

7 months ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0
  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0
  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0
  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0
  • Tanzania’s natural gas sector goes global with Dubai deal

    0 shares
    Share 0 Tweet 0
  • Privacy Policy
  • Contact

© 2023 LBNN - All rights reserved.

No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • Documentaries
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist

© 2023 LBNN - All rights reserved.